GRADE equity guidelines 4: considering health equity in GRADE guideline development: evidence to decision process
Por:
Pottie, K, Welch, V, Morton, R, Akl, EA, Eslava-Schmalbach, JH, Katikireddi, V, Singh, J, Moja, L, Lang, E, Magrini, N, Thabane, L, Stanev, R, Matovinovic, E, Snellman, A, Briel, M, Shea, B, Tugwell, P, Schunemann, H, Guyatt, G, Alonso-Coello, P
Publicada:
1 oct 2017
Resumen:
Objectives: The aim of this paper is to provide detailed guidance on how to incorporate health equity within the GRADE (Grading Recommendations Assessment and Development Evidence) evidence to decision process.
Study Design and Setting: We developed this guidance based on the GRADE evidence to decision framework, iteratively reviewing and modifying draft documents, in person discussion of project group members and input from other GRADE members.
Results: Considering the impact on health equity may be required, both in general guidelines and guidelines that focus on disadvantaged populations. We suggest two approaches to incorporate equity considerations: (1) assessing the potential impact of interventions on equity and (2) incorporating equity considerations when judging or weighing each of the evidence to decision criteria. We provide guidance and include illustrative examples.
Conclusion: Guideline panels should consider the impact of recommendations on health equity with attention to remote and underserviced settings and disadvantaged populations. Guideline panels may wish to incorporate equity judgments across the evidence to decision framework. This is the fourth and final paper in a series about considering equity in the GRADE guideline development process. This series is coming from the GRADE equity subgroup. (C) 2017 Elsevier Inc. All rights reserved.
Filiaciones:
Pottie, K:
Univ Ottawa, Bruyere Res Inst, Dept Family Med, Ottawa, ON, Canada
Univ Ottawa, Bruyere Res Inst, Dept Epidemiol & Community Med, Ottawa, ON, Canada
Univ Ottawa, Bruyere Res Inst, Epidemiol & Community Med, Ottawa, ON, Canada
Welch, V:
Univ Ottawa, Ottawa, ON, Canada
Morton, R:
Univ Sydney, NHMRC Clin Trials Ctr, Camperdown, NSW, Australia
Akl, EA:
Amer Univ Beirut, Dept Internal Med, Beirut, Lebanon
Eslava-Schmalbach, JH:
Univ Nacl Colombia, Fac Med, Grp Equ Hlth, Technol Dev Ctr Soc Colombiana Anestesiol & Reani, Bogota, Colombia
Katikireddi, V:
Univ Glasgow, MRC CSO Social & Publ Hlth Sci Unit, Publ Hlth, Glasgow, Lanark, Scotland
Singh, J:
Univ Alabama, Tuscaloosa, AL 35487 USA
Moja, L:
WHO, Dept Essential Med & Hlth Prod, Geneva, Switzerland
Lang, E:
Univ Calgary, Div Emergency Med, Dept Family Med, Calgary, AB, Canada
Magrini, N:
WHO, Dept Essential Med & Hlth Prod, Geneva, Switzerland
Thabane, L:
St Josephs Healthcare Hamilton, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada
Stanev, R:
Ottawa Hosp Res Inst, Ctr Practice Changing Res, Ottawa, ON, Canada
Dept Philosophy, Ottawa, ON, Canada
Matovinovic, E:
Chiang Mai Univ, Fac Med, Chiang Mai, Thailand
Snellman, A:
Swedish Agcy Hlth Technol Assessment & Assessment, Stockholm, Sweden
Briel, M:
Univ Basel Hosp, Dept Clin Res, Basel Inst Clin Epidemiol & Biostat, Basel, Switzerland
McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada
Shea, B:
Univ Ottawa, Bruyere Res Inst, Ottawa, ON, Canada
Tugwell, P:
Univ Ottawa, Dept Med, Fac Med, Ottawa, ON, Canada
Schunemann, H:
McMaster Univ, Hlth Sci Ctr, Dept Hlth Res Methods Evidence & Impact & Med, Hamilton, ON, Canada
Guyatt, G:
McMaster Univ, Hlth Sci Ctr, Dept Hlth Res Methods Evidence & Impact & Med, Hamilton, ON, Canada
Alonso-Coello, P:
CIBERESP IIB St Pau, Inst Invest Biomed, Ctr Cochrane Iberoamer, Barcelona, Spain
Green Accepted
|